Interplay between Mdm2 and HIPK2 in the DNA damage response

Xiao-Peng Zhang1, Feng Liu2, Wei Wang3

  • 1National Laboratory of Solid State Microstructures and Department of Physics, Nanjing University, Nanjing 210093, People's Republic of China Kuang Yaming Honors School, Nanjing University, Nanjing 210093, People's Republic of China.

Insights

The interplay between HIPK2 and Mdm2 regulates the p53 pathway during DNA damage. Mdm2-dependent HIPK2 degradation promotes survival after mild damage, while HIPK2 accumulation triggers apoptosis in severe DNA damage scenarios.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Systems Biology

Background:

  • The tumor suppressor p53 is crucial for the DNA damage response (DDR), inducing cell-cycle arrest or apoptosis.
  • Phosphorylation of p53 at Ser46 by HIPK2 is a key event for apoptosis induction.
  • HIPK2 is degraded by Mdm2, a negative regulator of p53, while HIPK2 also downregulates Mdm2.

Purpose of the Study:

  • To model the p53 pathway network, focusing on the Mdm2-HIPK2 interplay in the DDR.
  • To elucidate the role of this interplay in response to ultraviolet radiation-induced DNA damage.
  • To understand how these interactions dictate cell fate decisions (survival vs. apoptosis).

Main Methods:

  • Development of a four-module network model for the p53 pathway.
  • Numerical simulations to analyze pathway dynamics under varying DNA damage levels.
  • Investigating the impact of Mdm2-dependent HIPK2 degradation and its inhibition.

Main Results:

  • Mdm2-mediated degradation of HIPK2 promotes cell survival following mild DNA damage.
  • Inhibition of HIPK2 degradation is sufficient to induce apoptosis, regardless of damage severity.
  • Severe DNA damage leads to HIPK2 accumulation and increased p53 phosphorylation at Ser46, promoting apoptosis.
  • Multiple Mdm2 downregulation mechanisms ensure apoptosis in cells with irreparable DNA damage.

Conclusions:

  • The dynamic interplay between Mdm2 and HIPK2 is critical for regulating p53 activity in the DDR.
  • HIPK2 accumulation, driven by Mdm2 downregulation, is a key switch for apoptosis induction in response to severe DNA damage.
  • Targeting HIPK2 presents a promising strategy for cancer therapy by modulating the p53-mediated DDR.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K